SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-20-215349
Filing Date
2020-08-11
Accepted
2020-08-10 21:50:00
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC TO-C d151337dsctoc.htm SC TO-C 38938
2 EX-2.1 d151337dex21.htm EX-2.1 608474
3 EX-99.1 d151337dex991.htm EX-99.1 122613
4 EX-99.2 d151337dex992.htm EX-99.2 77284
  Complete submission text file 0001193125-20-215349.txt   848862
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filed by) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10790 ROSELLE STREET SAN DIEGO CA 92121
Business Address 10790 ROSELLE STREET SAN DIEGO CA 92121 858-352-4400
Pfenex Inc. (Subject) CIK: 0001478121 (see all company filings)

IRS No.: 271356759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-88253 | Film No.: 201090936
SIC: 2834 Pharmaceutical Preparations